Searched for
THE GENERAL RESERVE SURPLUS
Bringing back open-market buybacks through stock exchanges is the right decisionSEBI’s decision to restore open-market buybacks through stock exchanges marks a pragmatic regulatory shift that supports efficient capital ...- Just donate blood and get VIP into famous temple. The result is blood bank surplus at local hospitalsA unique program in Madhya Pradesh connects blood donation with VIP darshan at Omkareshwar Jyotirlinga temple. Devotees donating blood rece...
- RBI's reform package could pull $40-75b inflows, push rupee to 92-93 and keep August rate on holdThe RBI's recent announcements are expected to attract substantial foreign capital, potentially strengthening the rupee. Analysts anticipat...
- ED's Parimatch heat reaches Zepto; SPC's India deeptech pushZepto has come under the ED's scanner as part of its probe into Parimatch. This and more in today's ETtech Top 5.
- India meets FY26 fiscal deficit target of 4.4% of GDP; revenue deficit at 1.55%India's fiscal deficit reached the budgeted 4.4% of GDP for fiscal 2026. This eases immediate government finance worries. However, the focu...
- Delhi Gymkhana Club has MF investments worth Rs 200 crore, earned more from food and parties than sports: Financial reportDelhi Gymkhana Club saw its surplus surge nearly ten times to Rs 9.5 crore in 2023-24. Restaurants, bars, and banquets drove this revenue g...
- Wipro's Rs 15,000 crore share buyback at 23% premium: Should you buy before record date?Wipro has announced a Rs 15,000 crore share buyback. The record date is June 5, with shares to be repurchased at Rs 250 each. This offers a...
- RBI discontinues investment fluctuation reserve requirement for banksThe Reserve Bank of India has discontinued the Investment Fluctuation Reserve for commercial banks. This change takes effect from May 18, 2...
- Profit on paper, loss in reality: How a routine accounting tool is used to deceive and take investors for a rideAmortisation is a number most investors skip, but it can shape reported profit. On the surface, it looks routine: A company spreads the cos...
- ET Prime Special Series: Multibagger or Bankrupt - Part 58: The ICE veteran that quietly became an EV lightweighting storyMost auto ancillary investors think linear. Company makes Component X. EV disrupts Component X. Stock goes down. Every story does not fit t...
- Bajaj Auto's Rs 5,633 crore share buyback: Should you participate or avoid?Bajaj Auto is undertaking its largest share buyback at Rs 5,633 crore. The offer price of Rs 12,000 per share presents a premium for shareh...
- ET Prime Special Series: Multibagger or IBC - Part 57: Forging firm that supplies Tata, M&M, JCB. Nobody talks about it enoughFor over four decades, one company has been making crankshafts quietly and precisely, supplying customers from Tata Motors to Liebherr to M...
- Resilient, not shock-free: India charts path through war jittersIndia's economy faces challenges from the West Asia conflict. Rising oil prices and trade disruptions are impacting India. However, strong ...
- Tax shadow over charitable trusts with 'profit' motiveThree top-notch hospitals in Mumbai and a famous international spiritual organisation-all functioning as charitable trusts-have been denied...
- ET Prime Special Series: Multibagger or Bankrupt - Part 56: An acquisition, a divestment, and a JV for EV. Ready for re-rating?Bulls argue this company is becoming a complete mobility-platform supplier in India: Power solutions and aftermarket, braking and safety. B...
- ET Prime Special Series: Multibagger or Bankrupt – Part 55: This old-economy giant helped power India’s past. Its big test lies aheadSome companies face disruption at the level of products. Others face it at the level of technology. That is what makes this story more comp...
- Aurobindo Pharma announces schedule, record date for its Rs 800 crore share buybackAurobindo Pharma has announced an Rs 800 crore share buyback via the tender route, offering Rs 1,475 per share. The buyback opens April 23 ...
- Buyback alert! Last date to buy Aurobindo Pharma shares for Rs 800-crore share buyback. Check detailsAurobindo Pharma has announced an ₹800-crore buyback at ₹1,475 per share, with April 17, 2026 set as the record date—meaning investors must...
- The most dangerous number on an Indian balance sheet after debt – and how it is manipulatedDifferent years. Different companies. Different accounting tricks. One common story – an effort to show financial numbers which hide the tr...
- Britannia announces Rs 83/share as dividend, to dole out Rs 2,000 croreThe company will shell out Rs 1,997 crore as dividend, Rs 1,011 crore of which will go to the promoters and the rest to public shareholders.
Load More
